Enara Bio® recognizes the value of collaborating with external experts from academia and industry to develop our science into novel therapeutics that will improve treatment outcomes for cancer patients. We welcome enquiries about establishing new partnerships and collaborations, including joint efforts to expand our Dark Antigen™ discovery research to enable the development of new immunotherapies in multiple types of cancer.
If you are interested in partnering with us, then please contact us here.
Enara Bio has established partnerships with global pharmaceutical companies and world-leading academic institutions to support our scientific innovation and development strategies. Click on the icons below for more information about our latest collaborations: